Advertisements


Trillium Therapeutics doses first patient with TTI-622

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Magenta Therapeutics doses first patient in MGTA-145 Phase 1 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: personnelSource: nytApr 24th, 2019

Harpoon Therapeutics doses firs patient in HPN536 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2019

ProQR Therapeutics doses first patient in Phase 2/3 Illuminate sepofarsen trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Mirati Therapeutics doses first patient in Phase 1/2 MRTX849 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2019

Novus Therapeutics doses first patient in phase 1 clinical trial of OP0201

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Avenue Therapeutics doses first patient in Phase 3 trial of IV tramadol

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2018

Aptevo Therapeutics doses first patient in Phase 1/1b trial of APVO436

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Voyager Therapeutics doses first patient in RESTORE-1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 10th, 2018

Corcept Initiates Phase III Study for Cushing"s Syndrome

Corcept (CORT) doses first patient in the phase III study of relacorilant for the treatment of Cushing's syndrome. Corcept Therapeutics Inc. CORT announced that it has do.....»»

Category: worldSource: nytNov 20th, 2018

Corcept Therapeutics doses first patient in Phase 3 trial of relacorilant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Cara Therapeutics doses first patient in Phase 2 trial of Korsuva for pruritus

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Aclaris Therapeutics doses first patient in Phase 2 clinical trial of ATI-501

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

Aclaris Therapeutics doses first patient in ATI-502 pilot study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: dealsSource: nytApr 23rd, 2018

Precision Therapeutics, NAAF to provide patient registry for alopecia areata

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2019

Precision BioSciences doses first patient in PBCAR0191 Phase 1/2a clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2019

Acer Therapeutics announces publication of long-term vEDS patient registry data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2019

Trillium Therapeutics receives noncompliance notification from Nasdaq

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 11th, 2019

Trillium Therapeutics (TRIL) Presents At H.C. Wainwright & Co. Annual Global Life Sciences Conference - Slideshow

Trillium Therapeutics (TRIL) Presents At H.C. Wainwright & Co. Annual Global Life Sciences Conference - Slideshow.....»»

Category: topSource: seekingalphaApr 9th, 2019

Provention Bio doses first patient in Phase 3 PROTECT clinical trial of PRV-031

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2019

Drug company founder, execs exploited patients to sell opioid: U.S. prosecutor

The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray, fueling the U.S. opioid epidemic, a federal prosecutor said on Thursday at the end of a landmark trial......»»

Category: topSource: reutersApr 4th, 2019